SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Biotech Valuation -- Ignore unavailable to you. Want to Upgrade?

To: Biomaven who wrote (3797)5/15/2001 3:58:19 PM
From: scaram(o)uche  Respond to of 52153
 
I think that their rationale was that biotech investors were suddenly going to pull their cash out and invest in banks.



To: Biomaven who wrote (3797)5/15/2001 5:57:05 PM
From: Michael Young  Read Replies (1) | Respond to of 52153
 
Because rate cuts mean that institutional money will be attracted to more cyclical market sectors. Biotechs are seen as more "defensive" in nature, and attract flows when the economy is percieved at great risk.

MIKE


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News